Neuro imaging system gets clearance in USDecember 13, 2018
The US Food and Drug Administration has okayed a new imaging modality augmented reality (AR) GLOW800 surgical fluorescence for vascular neurosurgery.
GLOW800 allows surgeons to observe cerebral anatomy in natural colour, in combination with ICG (Indocyanine Green), augmented by real-time vascular flow in a single image, with full depth perception.
It provides the surgeon with a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery.
GLOW800 AR fluorescence is the first of many imaging modalities that will be based on the GLOW AR platform. GLOW AR modalities can be fully integrated into the ARveo digital augmented reality microscope, according to Leica Microsystems, the maker of the device.